全文获取类型
收费全文 | 109906篇 |
免费 | 1187篇 |
国内免费 | 834篇 |
出版年
2023年 | 160篇 |
2022年 | 215篇 |
2021年 | 679篇 |
2020年 | 415篇 |
2019年 | 444篇 |
2018年 | 12245篇 |
2017年 | 11021篇 |
2016年 | 8064篇 |
2015年 | 1459篇 |
2014年 | 1399篇 |
2013年 | 1828篇 |
2012年 | 5744篇 |
2011年 | 14045篇 |
2010年 | 12677篇 |
2009年 | 8835篇 |
2008年 | 10521篇 |
2007年 | 12072篇 |
2006年 | 926篇 |
2005年 | 1113篇 |
2004年 | 1443篇 |
2003年 | 1420篇 |
2002年 | 1144篇 |
2001年 | 559篇 |
2000年 | 437篇 |
1999年 | 277篇 |
1998年 | 107篇 |
1997年 | 97篇 |
1996年 | 83篇 |
1995年 | 76篇 |
1994年 | 63篇 |
1993年 | 85篇 |
1992年 | 171篇 |
1991年 | 180篇 |
1990年 | 120篇 |
1989年 | 92篇 |
1988年 | 143篇 |
1987年 | 108篇 |
1986年 | 79篇 |
1985年 | 81篇 |
1984年 | 88篇 |
1983年 | 63篇 |
1982年 | 42篇 |
1981年 | 47篇 |
1980年 | 44篇 |
1979年 | 56篇 |
1978年 | 35篇 |
1977年 | 43篇 |
1975年 | 34篇 |
1972年 | 273篇 |
1971年 | 287篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
Christofer Bj?rkelid Terese Bergfors Anand Kumar V. Raichurkar Kakoli Mukherjee Krishnan Malolanarasimhan Balachandra Bandodkar T. Alwyn Jones 《The Journal of biological chemistry》2013,288(25):18260-18270
Mycobacterium tuberculosis, the bacterial causative agent of tuberculosis, currently affects millions of people. The emergence of drug-resistant strains makes development of new antibiotics targeting the bacterium a global health priority. Pantothenate kinase, a key enzyme in the universal biosynthesis of the essential cofactor CoA, was targeted in this study to find new tuberculosis drugs. The biochemical characterizations of two new classes of compounds that inhibit pantothenate kinase from M. tuberculosis are described, along with crystal structures of their enzyme-inhibitor complexes. These represent the first crystal structures of this enzyme with engineered inhibitors. Both classes of compounds bind in the active site of the enzyme, overlapping with the binding sites of the natural substrate and product, pantothenate and phosphopantothenate, respectively. One class of compounds also interferes with binding of the cofactor ATP. The complexes were crystallized in two crystal forms, one of which is in a new space group for this enzyme and diffracts to the highest resolution reported for any pantothenate kinase structure. These two crystal forms allowed, for the first time, modeling of the cofactor-binding loop in both open and closed conformations. The structures also show a binding mode of ATP different from that previously reported for the M. tuberculosis enzyme but similar to that in the pantothenate kinases of other organisms. 相似文献
992.
David S. Tourigny Israel S. Fernández Ann C. Kelley Ramkrishna Reddy Vakiti Amit Kumar Chattopadhyay Stéphane Dorich Stephen Hanessian V. Ramakrishnan 《Journal of molecular biology》2013
Biosynthetically and chemically derived analogs of the antibiotic pactamycin and de-6-methylsalicylyl (MSA)-pactamycin have attracted recent interest as potential antiprotozoal and antitumor drugs. Here, we report a 3.1-Å crystal structure of de-6-MSA-pactamycin bound to its target site on the Thermus thermophilus 30S ribosomal subunit. Although de-6-MSA-pactamycin lacks the MSA moiety, it shares the same binding site as pactamycin and induces a displacement of nucleic acid template bound at the E-site of the 30S. The structure highlights unique interactions between this pactamycin analog and the ribosome, which paves the way for therapeutic development of related compounds. 相似文献
993.
994.
995.
996.
Katherine Reiter Debaditya Mukhopadhyay Hong Zhang Lauren E. Boucher Nirbhay Kumar Jürgen Bosch Michael J. Matunis 《The Journal of biological chemistry》2013,288(39):27724-27736
Small ubiquitin-related modifiers (SUMOs) are post-translationally conjugated to other proteins and are thereby essential regulators of a wide range of cellular processes. Sumoylation, and enzymes of the sumoylation pathway, are conserved in the malaria causing parasite, Plasmodium falciparum. However, the specific functions of sumoylation in P. falciparum, and the degree of functional conservation between enzymes of the human and P. falciparum sumoylation pathways, have not been characterized. Here, we demonstrate that sumoylation levels peak during midstages of the intra-erythrocyte developmental cycle, concomitant with hemoglobin consumption and elevated oxidative stress. In vitro studies revealed that P. falciparum E1- and E2-conjugating enzymes interact effectively to recognize and modify RanGAP1, a model mammalian SUMO substrate. However, in heterologous reactions, P. falciparum E1 and E2 enzymes failed to interact with cognate human E2 and E1 partners, respectively, to modify RanGAP1. Structural analysis, binding studies, and functional assays revealed divergent amino acid residues within the E1-E2 binding interface that define organism-specific enzyme interactions. Our studies identify sumoylation as a potentially important regulator of oxidative stress response during the P. falciparum intra-erythrocyte developmental cycle, and define E1 and E2 interactions as a promising target for development of parasite-specific inhibitors of sumoylation and parasite replication. 相似文献
997.
Manpreet Kaur Rawal Mohammad Firoz Khan Khyati Kapoor Neha Goyal Sobhan Sen Ajay Kumar Saxena Andrew M. Lynn Joel D. A. Tyndall Brian C. Monk Richard D. Cannon Sneha Sudha Komath Rajendra Prasad 《The Journal of biological chemistry》2013,288(34):24480-24493
The fungal ATP-binding cassette (ABC) transporter Cdr1 protein (Cdr1p), responsible for clinically significant drug resistance, is composed of two transmembrane domains (TMDs) and two nucleotide binding domains (NBDs). We have probed the nature of the drug binding pocket by performing systematic mutagenesis of the primary sequences of the 12 transmembrane segments (TMSs) found in the TMDs. All mutated proteins were expressed equally well and localized properly at the plasma membrane in the heterologous host Saccharomyces cerevisiae, but some variants differed significantly in efflux activity, substrate specificity, and coupled ATPase activity. Replacement of the majority of the amino acid residues with alanine or glycine yielded neutral mutations, but about 42% of the variants lost resistance to drug efflux substrates completely or selectively. A predicted three-dimensional homology model shows that all the TMSs, apart from TMS4 and TMS10, interact directly with the drug-binding cavity in both the open and closed Cdr1p conformations. However, TMS4 and TMS10 mutations can also induce total or selective drug susceptibility. Functional data and homology modeling assisted identification of critical amino acids within a drug-binding cavity that, upon mutation, abolished resistance to all drugs tested singly or in combinations. The open and closed Cdr1p models enabled the identification of amino acid residues that bordered a drug-binding cavity dominated by hydrophobic residues. The disposition of TMD residues with differential effects on drug binding and transport are consistent with a large polyspecific drug binding pocket in this yeast multidrug transporter. 相似文献
998.
Andreas D. Kistler Geetika Singh Mehmet M. Altintas Hao Yu Isabel C. Fernandez Changkyu Gu Cory Wilson Sandeep Kumar Srivastava Alexander Dietrich Katherina Walz Dontscho Kerjaschki Phillip Ruiz Stuart Dryer Sanja Sever Amit K. Dinda Christian Faul Jochen Reiser 《The Journal of biological chemistry》2013,288(51):36598-36609
Gain-of-function mutations in the calcium channel TRPC6 lead to autosomal dominant focal segmental glomerulosclerosis and podocyte expression of TRPC6 is increased in some acquired human glomerular diseases, particularly in membranous nephropathy. These observations led to the hypothesis that TRPC6 overactivation is deleterious to podocytes through pathological calcium signaling, both in genetic and acquired diseases. Here, we show that the effects of TRPC6 on podocyte function are context-dependent. Overexpression of TRPC6 alone did not directly affect podocyte morphology and cytoskeletal structure. Unexpectedly, however, overexpression of TRPC6 protected podocytes from complement-mediated injury, whereas genetic or pharmacological TRPC6 inactivation increased podocyte susceptibility to complement. Mechanistically, this effect was mediated by Ca2+/calmodulin-dependent protein kinase II (CaMKII) activation. Podocyte-specific TRPC6 transgenic mice showed stronger CaMKII activation, reduced podocyte foot process effacement and reduced levels of proteinuria during nephrotoxic serum nephritis, whereas TRPC6 null mice exhibited reduced CaMKII activation and higher levels of proteinuria compared with wild type littermates. Human membranous nephropathy biopsy samples showed podocyte staining for active CaMKII, which correlated with the degree of TRPC6 expression. Together, these data suggest a dual and context dependent role of TRPC6 in podocytes where acute activation protects from complement-mediated damage, but chronic overactivation leads to focal segmental glomerulosclerosis. 相似文献
999.
1000.